SLN Competitors & Alternatives

Compare Silence Therapeutics PLC with similar stocks in the same industry

Biotechnology

SLN

Main Stock
$10.68
Tradestie Score
55
Market Cap
$240.89M
Revenue Growth
2.0%
Analyst Upside
+173.1%

Top Competitors

231 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ZVRA Zevra Therapeutics, Inc. Common Stock
$10.06
$529.35M 4.7 55 Compare
MNPR Monopar Therapeutics Inc. Common Stock
$111.64
$522.78M - 51 Compare
LXRX Lexicon Pharmaceuticals, Inc.
$2.33
$512.39M - 53 Compare
RIGL Rigel Pharmaceuticals Inc. (New)
$37.43
$505.12M 1.9 58 Compare
RGNX REGENXBIO Inc.
$9.96
$493.52M - 50 Compare
INBX Inhibrx Biosciences, Inc. Common Stock
$82.72
$492.21M - 50 Compare
XOMA XOMA Royalty Corporation Common Stock
$40.17
$474.20M 28.2 56 Compare
ABSI Absci Corporation Common Stock
$7.93
$468.01M - 51 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$15.38
$463.20M - 60 Compare
SLDB Solid Biosciences Inc. Common Stock
$8.02
$457.09M - 52 Compare

Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)

231 stocks in this industry